Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 8/20 | 0.46 |
| ▸ | RARA | P10276 | 1/20 | 0.38 |
| ▸ | RARG | P13631 | 1/20 | 0.38 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.32 |
| ▸ | MPL | P40238 | 3/20 | 0.32 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.31 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22011103 | 0.89 | RARB (0.42) | RARBRARARARGABCB1HTR2A | |
| SCHEMBL22010983 | 0.87 | ALDH1A1 (0.38) | RARBRARARARGABCB1HTR2A | |
| SCHEMBL22011220 | 0.83 | RARB (0.33) | RARB | |
| SCHEMBL12735698 | 0.80 | RARB (0.53) | RARBRARARARGHTR2AMPL | |
| SCHEMBL18779782 | 0.79 | RARB (0.54) | RARBRARARARGHTR2AMPL | |
| SCHEMBL22011130 | 0.78 | MAOB (0.41) | HSD17B10 | |
| SCHEMBL22010998 | 0.78 | RARB (0.44) | RARBRARARARGABCB1MPL | |
| SCHEMBL10005521 | 0.78 | RARB (0.61) | RARBRARARARGHTR2AMPL | |
| SCHEMBL13111984 | 0.78 | RARB (0.64) | RARBRARARARGHTR2ATSHR | |
| SCHEMBL10301968 | 0.77 | RARB (0.55) | RARBRARARARGHTR2AMPL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10662378-B2 | Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2020-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10662378-B2 | Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display device | YBX1, ZKSCAN2, RCC1 | RARB 2226/4885RARA 1881/4885RARG 3543/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.